PRLD
Prelude Therapeutics Inc
3.70$
-3.2%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | -1,469.8% | -463.8% | |
| – | – | – | – | – | – | 25.3% | 11.0% | |
| – | – | – | – | – | – | 304.9% | 98.1% | |
| – | – | – | – | – | – | 60.2% | 234.0% | |
| – | – | – | – | – | – | 10.9% | 0.6% | |
| – | – | – | – | – | – | 1,288.4% | 440.4% | |
| – | – | – | – | – | – | -5.6% | -1.7% | |
| – | – | – | – | – | – | -1.7% | 204.4% | |
| – | – | – | – | – | – | -183.1% | 181.0% | |
| – | – | – | – | – | – | -1,480.7% | -464.3% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.